2025 Top 10 oral tablets Factory in the world

Jan 13, 2026

Leave a message

Sophia Zhang
Sophia Zhang
Sophia is in charge of the customized services at Guangzhou Weixin Biological Technology Co., Ltd. She is proficient in various customization aspects, including recipe design, label customization, etc. Her engineering expertise enables light customization and sample processing to meet diverse customer needs.

Introduction to Oral Tablets

Oral tablets are one of the most common and widely used forms of pharmaceutical and nutritional products. They are solid dosage forms that contain active ingredients in a pre - measured amount, typically compressed into a specific shape and size. Oral tablets offer several advantages, such as ease of administration, accurate dosing, stability during storage, and convenient packaging. They can be used to deliver a wide range of substances, including medications for treating various diseases, vitamins, minerals, and herbal supplements. The production of high - quality oral tablets requires advanced manufacturing technologies, strict quality control systems, and in - depth knowledge of pharmacology and formulation science.


1. Guangzhou Weixin Biological Technology Co., Ltd

Company Introduction

Guangzhou Weixin Biological Technology Co., Ltd is a leading player in the field of oral tablets production. Situated in the vibrant city of Guangzhou, which is a hub of economic and technological development in China, the company has established a strong reputation for its commitment to quality and innovation.


The company was founded with the vision of providing high - quality health products to consumers around the world. It has a state - of - the - art manufacturing facility that is equipped with the latest production equipment and adheres to strict international standards. The R & D department of Guangzhou Weixin is staffed with a team of experienced scientists and researchers who are constantly exploring new formulations and technologies to improve the efficacy and quality of their oral tablets.


Guangzhou Weixin focuses on a diverse range of oral tablet products. Their product portfolio includes nutritional supplements, such as multivitamins, probiotics, and herbal extracts. These supplements are designed to meet the different health needs of consumers, from boosting immunity to improving digestive health. The company also produces dietary products that are suitable for people with specific dietary requirements, such as low - calorie or high - fiber tablets.


In terms of quality control, Guangzhou Weixin has implemented a comprehensive quality management system. Every step of the production process, from raw material sourcing to finished product packaging, is strictly monitored. The company sources raw materials from reliable suppliers and conducts multiple quality checks to ensure the purity and potency of the ingredients. They also use advanced testing methods to verify the quality of the final products, including dissolution testing, content uniformity testing, and stability testing.


Features and Advantages in Oral Tablets

  • Advanced Formulation Technology: Guangzhou Weixin uses cutting - edge formulation techniques to ensure the optimal release and absorption of the active ingredients in their oral tablets. For example, they have developed special coating technologies that can protect the active ingredients from degradation in the stomach and ensure their targeted delivery to the intestines.
  • Customization Services: The company offers customization services for its oral tablet products. They can work with clients to develop personalized formulations based on specific requirements, such as unique ingredients, dosage forms, and packaging designs. This flexibility allows them to meet the diverse needs of different customers, including pharmaceutical companies, health food brands, and distributors.
  • Cost - effectiveness: Despite the high quality of their products, Guangzhou Weixin is able to offer competitive prices. This is due to their efficient production processes, economies of scale, and strategic sourcing of raw materials. Their cost - effective products make them an attractive option for both large - scale and small - scale customers.
  • Global Reach: With a well - established distribution network, Guangzhou Weixin's oral tablets are sold in many countries around the world. They have built long - term partnerships with international distributors and retailers, which enables them to expand their market share and reach a wider customer base.
  • Website: https://www.weixinchina.com/


2. Pfizer Inc.

Company Introduction

Pfizer is one of the most well - known and influential pharmaceutical companies in the world. Founded in 1849, it has a long - standing history of innovation and excellence in the development and production of healthcare products. Headquartered in New York, USA, Pfizer operates in more than 175 countries and has a large global workforce.


Pfizer's research and development efforts cover a wide range of therapeutic areas, including oncology, cardiology, immunology, and infectious diseases. The company has a vast portfolio of oral tablet medications. In oncology, for example, they have developed several life - saving oral chemotherapy drugs. These drugs are designed to target specific cancer cells while minimizing damage to normal cells. They have been shown to significantly improve the survival rates and quality of life for cancer patients.


In the field of cardiology, Pfizer's oral tablets play a crucial role in managing conditions such as high blood pressure and high cholesterol. Their antihypertensive drugs work by relaxing blood vessels, reducing the workload on the heart, and lowering blood pressure. Cholesterol - lowering drugs, on the other hand, inhibit the production of cholesterol in the liver, helping to prevent cardiovascular diseases.


Pfizer's manufacturing facilities are equipped with the latest technology and adhere to the strictest quality standards. The company invests heavily in quality control and assurance to ensure that every oral tablet produced meets the highest levels of safety, efficacy, and quality. They have a team of experts who oversee the entire production process, from the initial research and development to the final packaging and distribution.


Pfizer also has a strong commitment to social responsibility. They are actively involved in initiatives to improve access to healthcare in developing countries, conduct clinical trials in diverse populations, and support scientific research and education.


Features and Advantages in Oral Tablets

  • Extensive R & D Portfolio: Pfizer's large - scale research and development efforts result in a continuous stream of innovative oral tablet products. Their scientists are constantly exploring new therapeutic targets and developing novel drug candidates. This gives them a competitive edge in the market and allows them to address unmet medical needs.
  • Global Manufacturing Network: With manufacturing plants located around the world, Pfizer can ensure a stable supply of oral tablets to meet the global demand. Their global presence also enables them to adapt to local regulatory requirements and market conditions.
  • Clinical Evidence and Reputation: Pfizer's oral tablets are backed by extensive clinical research and evidence. The company has a long - standing reputation for producing high - quality and effective medications, which gives healthcare professionals and patients confidence in their products.
  • Collaborative Approach: Pfizer collaborates with academic institutions, research organizations, and other pharmaceutical companies to accelerate the development of new oral tablet therapies. These partnerships allow them to access a wider range of expertise and resources, leading to more innovative and effective products.


3. Novartis International AG

Company Introduction

Novartis is a Swiss multinational pharmaceutical company that is at the forefront of the global healthcare industry. Founded in 1996 through the merger of Ciba - Geigy and Sandoz, Novartis has since become a leader in the research, development, and production of a wide range of healthcare products, including oral tablets.


The company's research focuses on several key therapeutic areas, such as ophthalmology, neuroscience, and oncology. In ophthalmology, Novartis has developed oral tablets for the treatment of age - related macular degeneration and other eye diseases. These drugs work by targeting the underlying molecular mechanisms of the diseases, helping to slow down the progression and improve the visual function of patients.


In neuroscience, Novartis is involved in the development of oral medications for the treatment of neurological disorders such as multiple sclerosis and Alzheimer's disease. Their research aims to find new ways to modulate the nervous system and improve the quality of life for patients suffering from these debilitating conditions.


Novartis has a state - of - the - art manufacturing infrastructure. Their manufacturing plants are equipped with advanced technology and automated production lines, which ensure high - precision and efficient production of oral tablets. The company also places a strong emphasis on environmental sustainability in its manufacturing processes, implementing measures to reduce waste, energy consumption, and carbon emissions.


The company's commitment to patient - centricity is evident in its approach to drug development. Novartis conducts extensive clinical trials to ensure the safety and efficacy of its oral tablet products, and it also provides support and resources to patients to help them manage their conditions.


Features and Advantages in Oral Tablets

  • Innovative Drug Delivery Systems: Novartis is known for its development of innovative drug delivery systems for oral tablets. For example, they have developed technologies that can control the release of drugs over a specific period of time, allowing for more consistent drug levels in the body and reducing the frequency of dosing.
  • Patient - Focused Approach: The company's patient - centric approach means that they take into account the needs and preferences of patients when developing oral tablet products. This includes factors such as ease of administration, taste, and side - effect management.
  • Strong Intellectual Property Portfolio: Novartis has a large portfolio of patents and intellectual property related to its oral tablet technologies and products. This provides them with a competitive advantage in the market and protects their innovations from being copied by competitors.
  • Global Access Initiatives: Novartis is actively involved in initiatives to improve access to its oral tablet medications in developing countries. They have partnerships with governments, non - profit organizations, and other stakeholders to ensure that their life - saving drugs are available to those in need at affordable prices.


4. Sanofi

Company Introduction

Sanofi is a French multinational pharmaceutical company with a rich history dating back to 1973. It is a global leader in the healthcare industry, with a diverse portfolio of products, including oral tablets.


Sanofi's research and development efforts span multiple therapeutic areas, such as diabetes, vaccines, and rare diseases. In the field of diabetes, Sanofi has developed a range of oral antidiabetic drugs. These drugs work through different mechanisms, such as stimulating insulin secretion, reducing glucose production in the liver, and improving insulin sensitivity. They have been widely used in the treatment of type 2 diabetes, helping patients to control their blood sugar levels and prevent complications.


Sanofi is also a major player in the vaccine industry. Although vaccines are not typically oral tablets, the company's research and manufacturing capabilities in the pharmaceutical field are relevant to the production of oral tablet medications. Their expertise in vaccine development, such as antigen formulation and adjuvant technology, can be applied to the development of more effective oral tablet delivery systems.


In the area of rare diseases, Sanofi has made significant contributions. They have developed oral tablet medications for the treatment of some rare genetic disorders. These drugs are often the only available treatment options for patients with these rare conditions, and they can have a profound impact on the patients' lives.


Sanofi's manufacturing facilities are spread across the globe, and they are subject to strict quality control and regulatory requirements. The company invests in continuous improvement of its manufacturing processes to ensure the highest quality of its oral tablet products.


Features and Advantages in Oral Tablets

  • Specialized Therapeutic Focus: Sanofi's focus on specific therapeutic areas, such as diabetes and rare diseases, allows them to develop in - depth expertise in these fields. This enables them to create more targeted and effective oral tablet medications for patients with these conditions.
  • Global Manufacturing and Distribution Network: With manufacturing plants and distribution centers around the world, Sanofi can ensure a timely and reliable supply of oral tablets to patients in different regions. Their global presence also helps them to adapt to local market needs and regulatory requirements.
  • Research and Development Partnerships: Sanofi collaborates with academic institutions, research organizations, and biotech companies to drive innovation in oral tablet development. These partnerships bring together different perspectives and resources, leading to the discovery of new drugs and treatment approaches.
  • Patient Support Programs: The company offers comprehensive patient support programs for its oral tablet products. These programs provide patients with information, education, and access to resources to help them manage their conditions effectively.


5. Merck & Co., Inc. (known as MSD outside the United States and Canada)

Company Introduction

Merck & Co., Inc. is an American pharmaceutical company with a long - standing reputation for innovation and excellence. Founded in 1891, it has been at the forefront of the development and production of a wide range of healthcare products, including oral tablets.


Merck's research efforts cover multiple therapeutic areas, with a particular focus on oncology, infectious diseases, and immunology. In oncology, Merck has developed several breakthrough oral chemotherapy drugs. These drugs work by targeting specific molecular pathways in cancer cells, inhibiting their growth and spread. They have shown remarkable efficacy in clinical trials and have become standard treatments for many types of cancer.


In the field of infectious diseases, Merck has a strong portfolio of oral antiviral and antibacterial drugs. Their antiviral drugs are used in the treatment of diseases such as HIV/AIDS and hepatitis C, while their antibacterial drugs are effective against a wide range of bacterial infections.


Merck's manufacturing facilities are equipped with advanced technology and adhere to strict quality control standards. The company has a comprehensive quality management system that ensures the safety, efficacy, and quality of its oral tablet products. They also invest in research and development to improve the manufacturing processes, such as developing new tablet - coating technologies and improving the dissolution rates of the drugs.


Merck is also committed to corporate social responsibility. They are involved in initiatives to improve access to healthcare in developing countries, support scientific education, and promote environmental sustainability in their operations.


Features and Advantages in Oral Tablets

  • Groundbreaking Research: Merck's research has led to the development of several revolutionary oral tablet drugs. Their ability to identify new therapeutic targets and develop innovative drugs gives them a competitive edge in the market and helps to improve the lives of patients around the world.
  • Quality - Driven Manufacturing: The company's strict quality control measures ensure that every oral tablet produced meets the highest standards. Their manufacturing processes are constantly monitored and improved to ensure consistency and reliability.
  • Global Impact: Merck's products are used in over 140 countries, making a significant global impact on public health. Their global presence allows them to address the healthcare needs of diverse populations and contribute to the fight against major diseases.
  • Collaboration and Innovation Ecosystem: Merck collaborates with a wide range of partners, including academic institutions, startups, and other pharmaceutical companies. This collaboration ecosystem fosters innovation and helps the company to stay at the forefront of oral tablet development.


6. GlaxoSmithKline plc (GSK)

Company Introduction

GlaxoSmithKline is a British - American multinational pharmaceutical company. It was formed in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham. GSK has a broad portfolio of products, including oral tablets, across various therapeutic areas.


In the area of respiratory diseases, GSK has developed a number of oral tablet medications. These drugs are used in the treatment of conditions such as asthma and chronic obstructive pulmonary disease (COPD). They work by reducing inflammation in the airways, relaxing the smooth muscles of the lungs, and improving breathing.


GSK is also active in the field of vaccines and infectious diseases. Although vaccines are not oral tablets, the company's research and development capabilities in this area can be translated into the development of more effective oral tablet delivery systems for antiviral and antibacterial drugs.


In addition, GSK has a focus on oncology and has developed oral chemotherapy drugs. These drugs are designed to target specific cancer - related molecules, providing more targeted and less toxic treatment options for cancer patients.


GSK's manufacturing facilities are located around the world and are subject to strict regulatory requirements. The company invests in research and development to improve the quality and performance of its oral tablet products, such as developing new formulations to enhance drug solubility and bioavailability.


Features and Advantages in Oral Tablets

  • Diverse Therapeutic Portfolio: GSK's wide range of products in different therapeutic areas allows them to meet the diverse healthcare needs of patients. This diversity also provides them with a competitive advantage in the market, as they can offer a comprehensive range of oral tablet solutions.
  • Research and Development Expertise: The company has a large and experienced research and development team. Their expertise in areas such as drug discovery, formulation development, and clinical trials enables them to develop high - quality oral tablet products.
  • Global Manufacturing and Supply Chain: GSK's global manufacturing and supply chain network ensures a reliable supply of oral tablets to patients around the world. They have the ability to scale up production quickly to meet the increasing demand for their products.
  • Patient - Centered Innovation: GSK is committed to patient - centered innovation. They conduct extensive patient research to understand the needs and preferences of patients, and use this information to develop more user - friendly oral tablet products.


7. Johnson & Johnson

Company Introduction

Johnson & Johnson is a well - known American multinational corporation that operates in the healthcare sector. Founded in 1886, it has a long - standing reputation for producing high - quality healthcare products, including oral tablets.


The company has a diverse business portfolio, with segments in pharmaceuticals, medical devices, and consumer health. In the pharmaceutical segment, Johnson & Johnson has developed oral tablet medications for a variety of therapeutic areas, such as immunology, oncology, and neuroscience.


In immunology, Johnson & Johnson's oral tablets are used in the treatment of autoimmune diseases such as rheumatoid arthritis and psoriasis. These drugs work by modulating the immune system, reducing inflammation, and improving the symptoms of the diseases.


In oncology, the company has a number of oral chemotherapy drugs. These drugs are designed to target specific cancer - related pathways, and they have shown promising results in clinical trials.


Johnson & Johnson's manufacturing facilities are known for their high - quality standards and advanced technology. The company has a strict quality control system that ensures the safety and efficacy of its oral tablet products. They also invest in research and development to improve the manufacturing processes and develop new formulations.


Features and Advantages in Oral Tablets

  • Integrated Healthcare Approach: Johnson & Johnson's ability to operate across different segments of the healthcare industry (pharmaceuticals, medical devices, and consumer health) allows them to take an integrated approach to oral tablet development. They can leverage their knowledge and resources from different areas to create more comprehensive healthcare solutions.
  • Strong Brand Reputation: The company's long - standing brand reputation gives consumers and healthcare professionals confidence in their oral tablet products. Their commitment to quality and innovation has made them a trusted name in the healthcare industry.
  • Global Reach and Local Adaptation: Johnson & Johnson has a global presence, with operations in over 60 countries. They are able to adapt their products to local market needs and regulatory requirements, ensuring that their oral tablets are accessible and suitable for patients around the world.
  • Research and Development Investment: The company invests heavily in research and development, which enables them to stay at the forefront of oral tablet technology. Their R & D efforts focus on developing new drugs, improving drug delivery systems, and enhancing the overall performance of their products.


8. AstraZeneca

Company Introduction

AstraZeneca is a British - Swedish multinational pharmaceutical company. It was formed in 1999 through the merger of Astra AB and Zeneca Group. AstraZeneca has a strong focus on research and development, with a portfolio of oral tablet medications in several therapeutic areas.


In the field of oncology, AstraZeneca has developed a number of breakthrough oral chemotherapy drugs. These drugs target specific cancer - related proteins and pathways, providing more targeted and effective treatment options for cancer patients. For example, their drugs for lung cancer have been shown to significantly improve the survival rates and quality of life of patients.


In cardiovascular and metabolic diseases, AstraZeneca's oral tablets are used in the treatment of conditions such as high blood pressure, high cholesterol, and diabetes. These drugs work by regulating blood pressure, lipid levels, and blood sugar levels, respectively.


AstraZeneca's manufacturing facilities are equipped with state - of - the - art technology and adhere to strict quality control standards. The company is committed to continuous improvement in its manufacturing processes, with a focus on reducing waste, improving efficiency, and ensuring product quality.


Features and Advantages in Oral Tablets

  • Innovative Oncology Research: AstraZeneca's research in oncology has led to the development of several innovative oral tablet drugs. Their ability to identify new cancer - related targets and develop drugs to attack them gives them a competitive edge in the oncology market.
  • Multidisciplinary Research Teams: The company has multidisciplinary research teams that bring together experts from different fields, such as medicine, biology, chemistry, and engineering. This collaborative approach allows them to develop more comprehensive and effective oral tablet solutions.
  • Global Clinical Trial Network: AstraZeneca conducts clinical trials around the world, which enables them to test their oral tablet products in diverse patient populations. This helps to ensure the safety and efficacy of their drugs in different ethnic groups and geographical regions.
  • Sustainable Manufacturing Practices: The company is committed to sustainable manufacturing practices in the production of its oral tablets. They are implementing measures to reduce their environmental impact, such as using renewable energy sources and reducing water consumption in their manufacturing facilities.


9. Eli Lilly and Company

Company Introduction

Eli Lilly and Company is an American pharmaceutical company that was founded in 1876. It has a long - standing history of innovation in the development and production of healthcare products, including oral tablets.


Eli Lilly's research focuses on several key therapeutic areas, such as diabetes, oncology, and neuroscience. In diabetes, the company has developed a range of oral antidiabetic drugs. These drugs work through different mechanisms, such as increasing insulin sensitivity, suppressing glucagon secretion, and enhancing glucose uptake by cells. They have been widely used in the management of type 2 diabetes, helping patients to control their blood sugar levels and prevent complications.


In oncology, Eli Lilly has developed oral chemotherapy drugs that target specific cancer - related pathways. These drugs are designed to be more effective and less toxic than traditional chemotherapy drugs, providing a better treatment option for cancer patients.


In neuroscience, the company is involved in the development of oral medications for the treatment of neurological disorders such as depression and Alzheimer's disease. Their research aims to find new ways to modulate the brain's neurotransmitter systems and improve the cognitive and emotional functions of patients.


Eli Lilly's manufacturing facilities are equipped with advanced technology and adhere to strict quality control standards. The company has a comprehensive quality management system that ensures the safety, efficacy, and quality of its oral tablet products.


Features and Advantages in Oral Tablets

  • Patient - Centered Innovation: Eli Lilly is committed to patient - centered innovation. They conduct extensive patient research to understand the needs and preferences of patients, and use this information to develop more convenient and effective oral tablet products. For example, they have developed tablets with improved taste and ease of swallowing.
  • Long - Standing Research Expertise: The company's long - standing history in research and development gives them a deep understanding of the pharmaceutical industry. Their research expertise allows them to develop innovative oral tablet drugs and stay at the forefront of medical science.
  • Global Access Initiatives: Eli Lilly is involved in initiatives to improve access to its oral tablet medications in developing countries. They have partnerships with governments, non - profit organizations, and other stakeholders to ensure that their life - saving drugs are available to those in need at affordable prices.
  • Strong Intellectual Property Portfolio: The company has a large portfolio of patents and intellectual property related to its oral tablet technologies and products. This provides them with a competitive advantage in the market and protects their innovations from being copied by competitors.


10. Takeda Pharmaceutical Company Limited

Company Introduction

Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. Founded in 1781, it is one of the oldest and most respected pharmaceutical companies in the world.


Takeda's research and development efforts cover a wide range of therapeutic areas, including gastroenterology, oncology, and rare diseases. In gastroenterology, Takeda has developed oral tablet medications for the treatment of conditions such as irritable bowel syndrome and ulcerative colitis. These drugs work by regulating the function of the digestive system, reducing inflammation, and improving the symptoms of the diseases.


In oncology, Takeda has a number of oral chemotherapy drugs. These drugs are designed to target specific cancer - related molecules, providing more targeted and less toxic treatment options for cancer patients.


In the area of rare diseases, Takeda has made significant contributions. They have developed oral tablet medications for the treatment of some rare genetic disorders. These drugs are often the only available treatment options for patients with these rare conditions, and they can have a profound impact on the patients' lives.


Takeda's manufacturing facilities are equipped with advanced technology and adhere to strict quality control standards. The company has a long - standing tradition of quality and innovation, and it is committed to continuous improvement in its manufacturing processes.


Features and Advantages in Oral Tablets

  • Deep Therapeutic Expertise: Takeda's focus on specific therapeutic areas, such as gastroenterology and rare diseases, allows them to develop in - depth expertise in these fields. This enables them to create more targeted and effective oral tablet medications for patients with these conditions.
  • Cultural and Global Perspective: As a Japanese company with a global presence, Takeda brings a unique cultural perspective to its research and development. They are able to combine traditional Japanese medicine knowledge with modern scientific research, leading to the development of innovative oral tablet products.
  • Patient - Focused Care: The company is committed to patient - focused care. They provide comprehensive support and resources to patients who use their oral tablet products, including educational materials, patient assistance programs, and access to healthcare professionals.
  • Global Research and Development Network: Takeda has a global research and development network that allows them to collaborate with scientists and researchers from around the world. This global collaboration enables them to access a wider range of expertise and resources, leading to more innovative and effective oral tablet products.


Summary

The top 10 oral tablets factories in the world, as presented above, represent a diverse range of companies with unique strengths and contributions to the field. Guangzhou Weixin Biological Technology Co., Ltd stands out with its focus on customization, cost - effectiveness, and advanced formulation technology, providing high - quality nutritional and dietary oral tablets.


The global pharmaceutical giants such as Pfizer, Novartis, and Sanofi have extensive research and development capabilities, large - scale manufacturing networks, and a wide portfolio of oral tablet medications targeting various therapeutic areas. Their long - standing reputations, backed by extensive clinical evidence, give patients and healthcare professionals confidence in their products.


Companies like Merck, GlaxoSmithKline, and Johnson & Johnson have a strong commitment to innovation, with breakthrough research leading to the development of revolutionary oral tablet drugs. They also have a global reach and are involved in initiatives to improve access to healthcare in developing countries.


AstraZeneca, Eli Lilly, and Takeda Pharmaceutical bring their own unique perspectives, whether it's in oncology research, patient - centered innovation, or deep therapeutic expertise in specific areas.


Overall, these companies play a crucial role in meeting the global demand for high - quality oral tablet products, contributing to the improvement of public health and the well - being of people around the world. Their continuous innovation, commitment to quality, and patient - focused approaches will likely drive the future development of the oral tablets industry.


Send Inquiry